Gavle Sjukhus

Gävle 801 88

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Coronary Revascularization, KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Myocardial Infarction, Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer, Stroke

Studies at this site

• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) — Recruiting now
• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). — Completed
• A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment — Stopped early
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling